bharangin has been researched along with cysteine in 1 studies
Studies (bharangin) | Trials (bharangin) | Recent Studies (post-2010) (bharangin) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
---|---|---|---|---|---|
6 | 0 | 3 | 40,132 | 418 | 11,457 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, BB; Das, J; Francis, SK; Gupta, SC; Kannappan, R; Kim, J; Nair, MS; Rahman, GM; Raveendran, R | 1 |
1 other study(ies) available for bharangin and cysteine
Article | Year |
---|---|
Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF-κB-reg
Topics: Apoptosis; Blotting, Western; Carcinogens; Cell Line, Tumor; Cysteine; Electrophoretic Mobility Shift Assay; Flavonoids; Gene Expression; Genes, Reporter; Humans; Immunohistochemistry; Magnetic Resonance Spectroscopy; Mass Spectrometry; NF-kappa B; Phosphorylation | 2011 |